News

Breakthroughs and approvals we can expect in the coming year.

Union therapeutics is also developing the drug for treatment of atopic dermatitis and hidradenitis suppurativa.

ICYMI, this week we had stories about what to look forward to in 2023, psoriasis challenges, NDA submissions for berdazimer gel, and more.

Answers to some common questions about providing telehealth services in 2023.

The Dermatology Times® Editorial Advisory Board members share what they hope to see in 2023.

ICYMI, this week we had stories about the top 5 articles of 2022, adjuvant treatment for Merkel cell carcinoma, favorite skin care products of 2022, and more.

Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are trending for the month of December.

A look back at benzene found in personal care products throughout the year and how companies have responded.

Dermatology Times®’ Editorial Board offers insight on what they loved about 2022, and what they hope to see in 2023.

As 2022 comes to a close, take a look at the top 5 articles from the year.

ICYMI, this week we had stories about roflumilast cream for plaque psoriasis, a conversation about JAK inhibitors for atopic dermatitis, mental health related to vitiligo, and more.

Arcutis Biotherapeutics' indication expansion is based on data from MUSE studies.

ICYMI, this week we had stories about holistic treatment for atopic dermatitis management, a recap of the 2022 Revolutionizing Atopic Dermatitis Conference, unmet needs in acne management, and more.

The PharmaJet Stratis Needle-free Injection System’s vaccine could help prevent a rare but aggressive form of skin cancer.

ICYMI, this week we had stories about the upcoming 2023 South Beach Symposium Meeting, acetic acid for wound healing, CBD for acne treatment, and more.

ICYMI, this week we had stories about characteristics of generalized pustular psoriasis, the psychosocial impact of vitiligo, new laser treatments for acne, and more.

In this week’s Pointers with Dr Portela, the 208SkinDoc, asks consumers about the basics of skin health and skin care.

Recent, continued research in genetic profiling has made personalized medicine more of a reality and brought the concept a step closer to potential regular use in general dermatology practice.

Happy Thanksgiving from the Dermatology Times® Editorial Advisory Board and editors!

Using pooled 52-week results from TRuE-AD1 and TRuE-AD2, investigators examined how the topical JAK1/JAK 2 inhibitor affects patient feelings of skin pain, discomfort, anxiety, and depression.

Dermoscopy is a valuable tool in differentiating regular pigmented lesions from dangerous skin cancers. At SDPA 2022, Orit Markowitz, MD, summarizes skin of color dermoscopy.

After reporting initial data earlier this year, investigators presented a fuller analysis in a poster at the 2022 SDPA Annual Fall Dermatology Conference.

The greatest improvements in quality of life measures were seen in the 300 mg tralokinumab group.

Click here to see a preview of what to expect this week.

ICYMI, this week we had stories about IL-17 inhibitor durability in plaque psoriasis, benzene contamination in dry shampoo products, an interview with Muneeb Shah, DO, and more.

November kicks off National Healthy Skin Month, presenting an opportunity to learn new habits for healthier skin.

Valisure, an independent laboratory, recently sent a Citizen's Petition to the FDA regarding high levels of benzene found in dry shampoo products.

ICYMI, this week we had stories about blastic plasmacytoid dendritic cell neoplasm, epidermolysis bullosa, an interview with Seth Matarasso, MD, and more.

Christopher Bunick, MD, PhD, shares his thoughts on the latest report of concerning levels of benzene, a human carcinogen, found in dry shampoos recalled last month.

ICYMI, this week we had stories about product recalls due to benzene, advanced wound care in the US, a Fall Clinical recap, and more.